EG COVID vaccine
- Generic Name
- EG COVID vaccine
Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- EyeGene Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT05188469
- Locations
- 🇦🇺
Holdsworth House, Sydney, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath